With reference to the release 12 January and the offer document for offer to
shareholders in Bionor Immuno, Nutri Pharma announces that it has received
acceptances for 96.54 % of the shares in Bionor Immuno. The offer is still
subject to the conditions referred to in the offer. "
[HUG#1375421]
| Titel | Leser |
|---|---|
1562 | |
1324 | |
1275 | |
1235 | |
519 |